TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients

por Villalba, Maria, Exposito, Francisco, Pajares, Maria Jose, Sainz, Cristina, Redrado, Miriam, Remirez, Ana, Wistuba, Ignacio, Behrens, Carmen, Jantus-Lewintre, Eloisa, Camps, Carlos, Montuenga, Luis M., Pio, Ruben, Lozano, Maria Dolores, de Andrea, Carlos, Calvo, Alfonso
Publicado 2019

A model based on the quantification of complement C4c, CYFRA 21–1 and CRP exhibits high specificity for the early diagnosis of lung cancer

por AJONA, DANIEL, REMIREZ, ANA, SAINZ, CRISTINA, BERTOLO, CRISTINA, GONZALEZ, ALVARO, VARO, NEREA, LOZANO, MARÍA D, ZULUETA, JAVIER J, MESA-GUZMAN, MIGUEL, MARTIN, ANA C, PEREZ-PALACIOS, ROSA, PEREZ-GRACIA, JOSE LUIS, MASSION, PIERRE P, MONTUENGA, LUIS M, PIO, RUBEN
Publicado 2021

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

por Redin, Esther, Garmendia, Irati, Lozano, Teresa, Serrano, Diego, Senent, Yaiza, Redrado, Miriam, Villalba, Maria, De Andrea, Carlos E, Exposito, Francisco, Ajona, Daniel, Ortiz-Espinosa, Sergio, Remirez, Ana, Bertolo, Cristina, Sainz, Cristina, Garcia-Pedrero, Juana, Pio, Ruben, Lasarte, Juan, Agorreta, Jackeline, Montuenga, Luis M, Calvo, Alfonso
Publicado 2021

Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer

por Bocanegra, Ana, Fernández‐Hinojal, Gonzalo, Ajona, Daniel, Blanco, Ester, Zuazo, Miren, Garnica, Maider, Chocarro, Luisa, Alfaro‐Arnedo, Elvira, Piñeiro‐Hermida, Sergio, Morente, Pilar, Fernández, Leticia, Remirez, Ana, Echaide, Miriam, Martinez‐Aguillo, Maite, Morilla, Idoia, Tavira, Beatriz, Roncero, Alejandra, Gotera, Carolina, Ventura, Alfonso, Recalde, Nerea, Pichel, José G, Lasarte, Juan José, Montuenga, Luis, Vera, Ruth, Pio, Ruben, Escors, David, Kochan, Grazyna
Publicado 2023